EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

MicroRNA ‐15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductal adenocarcinoma

Patrick J Ryan, Bethany C Guerra, Peter P Nghiem, Steven E Riechman, Mariana Janini-Gomes, James D Fluckey iD

Physiological Reports · 2026-07 · 14 (14)

DOI: 10.14814/phy2.71015 ↗

At a glance

Journal article in Physiological Reports, published online on 2026-07-16. Written by Patrick J Ryan and 5 co-authors. Institution: Muscle Biology Laboratory, Department of Kinesiology and Sports Management, Texas A&M University, College Station, Texas, USA. Major MEDLINE topics: MicroRNAs, Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. 55 references. The full text is freely available (open access, CC BY 4.0). Funded by: DOD | US Army | MEDCOM | Congressionally Directed Medical Research Programs (CDMRP), Congressionally Directed Medical Research Programs.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Dysregulated cellular protein metabolism is a key hallmark of pancreatic ductal adenocarcinoma (PDAC). However, much remains to be learned about how this process is regulated in cancerous cells. Here we investigated the role of two co‐transcribed microRNA (miRNA) species, miR‐15a/16, in regulating cellular protein translation, cell growth, metabolic processes, and clinical features in PDAC. Using cultured PDAC models, we show that overexpression of miR‐15a/16 in cancerous cells slows proliferation and attenuates protein synthesis rates. Bioinformatics analysis reveals that these miRNAs target a broad suite of pathophysiological and metabolic pathways, including numerous genes in cancer‐ and protein‐related processes. Finally, using publicly available patient data, we report that miR‐15a/16 expression is lower in PDAC tumors and in patients with pancreatitis than in healthy controls, and that high expression of miR‐15a/16 in tumors is associated with improved survival in patients. Our results indicate that miR‐15a/16 act as regulators of protein metabolism in PDAC, with potential clinical implications for the management of this devastating disease.

Subjects

MeSH terms (MEDLINE)

MicroRNAsCarcinoma, Pancreatic DuctalPancreatic NeoplasmsHumansGene Expression Regulation, NeoplasticCell Line, TumorCell ProliferationFemale

Author keywords

MetabolisimPDACcancermiRNAproteostasis

Substances

MicroRNAsMIRN15 microRNA, humanMIRN16 microRNA, human

Authors and institutions

  • Muscle Biology Laboratory, Department of Kinesiology and Sports Management, Texas A&M University, College Station, Texas, USA.
  • Department of Veterinary Integrative Biosciences, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, College Station, Texas, USA.

ORCID profiles: James D Fluckey

Funding

  • DOD | US Army | MEDCOM | Congressionally Directed Medical Research Programs (CDMRP)
  • Congressionally Directed Medical Research Programs

Cite

APA

Ryan, P. J., Guerra, B. C., Nghiem, P. P., Riechman, S. E., Janini-Gomes, M., & Fluckey, J. D. (2026). MicroRNA ‐15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductal adenocarcinoma. Physiological Reports, 14(14). https://doi.org/10.14814/phy2.71015

Vancouver

Ryan PJ, Guerra BC, Nghiem PP, Riechman SE, Janini-Gomes M, Fluckey JD. MicroRNA ‐15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductal adenocarcinoma. Physiological Reports. 2026;14(14). doi:10.14814/phy2.71015

BibTeX
@article{Ryan2026,
  author = {Ryan, Patrick J and Guerra, Bethany C and Nghiem, Peter P and Riechman, Steven E and Janini-Gomes, Mariana and Fluckey, James D},
  title = {MicroRNA ‐15a/16 regulate protein metabolism and are associated with clinical outcomes in pancreatic ductal adenocarcinoma},
  journal = {Physiological Reports},
  year = {2026},
  volume = {14},
  number = {14},
  doi = {10.14814/phy2.71015}
}
Start for free →